Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalOperating Expenses
Others
Ratios

Inogen (INGN) EBITDA (2016 - 2022)

Inogen (INGN) has disclosed EBITDA for 10 consecutive years, with -$9.9 million as the latest value for Q3 2022.

  • On a quarterly basis, EBITDA fell 213.89% to -$9.9 million in Q3 2022 year-over-year; TTM through Sep 2022 was -$18.8 million, a 350.28% decrease, with the full-year FY2021 number at -$5.3 million, down 1.37% from a year prior.
  • EBITDA was -$9.9 million for Q3 2022 at Inogen, up from -$23.1 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $16.1 million in Q3 2018 to a low of -$23.1 million in Q4 2021.
  • A 5-year average of $3.0 million and a median of $5.5 million in 2019 define the central range for EBITDA.
  • Peak YoY movement for EBITDA: surged 1974.49% in 2018, then tumbled 356.34% in 2021.
  • Inogen's EBITDA stood at $10.1 million in 2018, then crashed by 116.95% to -$1.7 million in 2019, then plummeted by 196.19% to -$5.1 million in 2020, then plummeted by 356.34% to -$23.1 million in 2021, then soared by 57.08% to -$9.9 million in 2022.
  • Per Business Quant, the three most recent readings for INGN's EBITDA are -$9.9 million (Q3 2022), -$23.1 million (Q4 2021), and $8.7 million (Q3 2021).